RYReetika Malik Yadav

Reetika Malik Yadav

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Reetika Malik Yadav has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Manisha Madkaikar

    Department of Transfusion Medicine, ICMR-National Institute for Research on Blood and Immune Disorders (NIRBID), formerly known as Indian Council of Medical Research ICMR-National Institute of Immunohaematology (NIIH), India

    11 shared publications
  • Umair Ahmed Bargir

    Paediatric Immunology and Leucocytes Biology Department ICMR‐National Institute of Immunohematology Mumbai India

    10 shared publications
  • Aparna Dalvi

    Paediatric Immunology and Leucocytes Biology Department ICMR‐National Institute of Immunohematology Mumbai India

    5 shared publications
  • Maya Gupta

    Paediatric Immunology and Leucocytes Biology Department ICMR‐National Institute of Immunohematology Mumbai India

    5 shared publications
  • Priyanka Setia

    Indian Council of Medical Research -National Institute of Immunohematology (ICMR -NIIH), 13th Floor, New Multistorey Building, KEM Hospital, Parel, Mumbai 400012, India

    4 shared publications
  • Sagar Bhattad

    Aster CMI Hospital

    4 shared publications

Latest Publications

  • CD8 + T cells surpass NK cells in granule release assay: Implications for diagnosing primary HLH

    by Maya Gupta, Shweta Shinde, Aparna Dalvi, Reetika Malik Yadav, Umair Ahmed Bargir, Lavina Temkar, Manisha Madkaikar

  • Augmenting the Jeffrey Modell Criteria for Optimising Screening for Inborn Errors of Immunity

    by Reetika Malik Yadav, Lavina Temkar, Umair Ahmed Bargir, Maya Gupta, Aparna Dalvi, Shweta Shinde, Manisha Madkaikar

    Jeffrey Modell warning signs have been used to guide screening for inborn errors of immunity (IEIs) for over three decades now, but may lack sensitivity for noninfectious presentations. Our study explored JMF signs along with additional signs and some laboratory parameters and assessed their effectiveness for guiding molecular screening for IEIs. We retrospectively analysed 100 patients suspected of IEI referred to ICMR‐National Institute of Immunohaematology from immunology clinics who underwent whole‐exome sequencing (WES), with pathogenic ( n = 50) and no variants ( n = 50). We evaluated clinical presentations other than JMF—autoimmunity, autoinflammation, vaccine complications, fever with bi‐cytopenia, consanguinity and laboratory parameters—absolute lymphocyte count, low naïve T cell (%) and hypogammaglobulinaemia at initial presentation. Thirty‐two models with different combinations of additional signs along with JMF score were evaluated based on the AIC score to determine the best model. The model was validated on WES results of 219 patients. The JMF scores of the pathogenic/likely pathogenic group (3.54 ± 1.92) were significantly higher than those of the no variants group (1.34 ± 1.28) ( p < 0.05). The best model, inclusive of consanguinity, presence of autoimmunity, vaccine complications, hypogammaglobulinaemia and low naïve T cell (%) with JMF, had a sensitivity and specificity of 82% and 67%, respectively, compared to sensitivity and specificity of 84% and 61% for JMF alone. Our study shows that the presence of any two among parental consanguinity, presence of autoimmunity, vaccine complications and low naïve T cell (%) improves the specificity of JMF criteria in guiding molecular screening for IEIs.

  • Open Access

    Clinical, Genetic, and Immunological Spectrum of CHAI and LATAIE Patients from a Tertiary Referral Centre in India

    by Priyanka Setia, Umair Ahmed Bargir, Mukesh Desai, Aparna Dalvi, Shweta Shinde, Neha Jodhawat, Pallavi Gaikwad, Sagar Bhattad, Chandrakala Shainmukhaih, Maya Gupta, et al.

    Primary immune regulatory disorders (PIRDs) are a group of conditions characterised by a loss of immune tolerance. Two such disorders, CHAI and LATAIE, share common molecular mechanisms, leading to significant clinical overlap. Here, we report demographic, clinical, immunological, and molecular findings in 29 patients referred from different parts of India with a diagnosis of CHAI or LATAIE. LATAIE patients demonstrated a higher prevalence of consanguinity, while CHAI patients more often had a positive family history. Both disorders presented with overlapping clinical features, predominately autoimmune cytopenias, benign lymphoproliferation, and inflammatory bowel disease (IBD). However, the incidence of recurrent infections, otitis media, bronchiectasis, and hypogammaglobulinemia was higher among LATAIE patients as compared to CHAI. Flow cytometry analysis revealed significant differences in T cell subsets, particularly in percentages of CD4+ naïve cells and T regulatory cells (Treg), between the two disorders. B cell abnormalities were also observed. Molecular diagnosis was achieved using targeted or clinical exome sequencing, and specific protein expression was employed to validate the novel variants.

  • Open Access

    Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India

    by Aparna Dalvi, Lavina Temkar, Mukesh Desai, Swati Garg, Jahnavi Aluri, Gouri Hule, Umair Ahmed Bargir, Priyanka Setia, Priyanka Kambli, Amruta Dhawale, et al.

    Mendelian susceptibility to mycobacterial disease (MSMD) is a rare syndrome characterized by increased and selective susceptibility to weakly virulent mycobacteria and other intramacrophagic pathogens. This study emphasizes the utility of immunological and functional assays in diagnosing MSMD by analyzing clinical, immunological, and genetic features in 50 Indian patients. Immunological workup included lymphocyte subset analysis, nitroblue tetrazolium test (NBT), and flow cytometric assessment of IFN-γR1 (CD119), IL-12Rβ1 (CD212), and phosphorylated STAT1/STAT4 following cytokine stimulation. Functional assays measured IFN-γ and IL-12p70 production. Genetic evaluation was performed using whole-exome or Sanger sequencing. The median age at onset was 3 mo. BCG complications were the most common presentation (96%), while 4% had non-tuberculous mycobacterial infections. Additional infections included Mycobacterium tuberculosis, Salmonella spp., Candida spp., and multiple types of viruses. IL-12Rβ1 deficiency was the most frequent diagnosis, with 10 novel variants in the IL12RB1 gene identified. These results demonstrate that combining flow cytometry with functional and genetic analyses enables accurate and timely MSMD diagnosis.

  • Navigating the Gray Zone: Differentiating Sepsis and Secondary HLH in Adults Using T Cell Activation Markers

    by Shilpi Saxena, Manisha Madkaikar, Fnu Shweta, Reetika Malik Yadav, Umair A. Bargir, Maya Gupta, Harleen Kaur, Saleem Amjad Mirza, Parikshit Sanyal, Purushotham Godavarthy, et al.

  • Open Access

    Common Variable Immunodeficiency Disorder: A Decade of Insights from a Cohort of 150 Patients in India and the Use of Machine Learning Algorithms to Predict Severity

    by Umair Ahmed Bargir, Priyanka Setia, Mukesh Desai, Chandrakala S, Aparna Dalvi, Shweta Shinde, Maya Gupta, Neha Jodhawat, Amrutha Jose, Mayuri Goriwale, et al.

    Common Variable Immunodeficiency (CVID) is a heterogeneous disorder characterized by impaired antibody production and recurrent infections. In this study we investigated the clinical and immunological features of CVID in Indian patients and develops a machine learning model for predicting disease severity. We retrospectively analyzed 150 patients diagnosed with CVID over a decade at a tertiary care center in India. The median age of diagnosis was 18 years, with a male predominance (62%). The majority of patients (66.6%) had a severe phenotype, with recurrent respiratory tract infections being the most common clinical manifestation (84.2%). Gastrointestinal complications were observed in 45% of patients, while autoimmune manifestations were seen in 21%. All patients exhibited hypogammaglobulinemia. IgA levels varied, with 7.8% normal and 14.5% undetectable. IgM levels were decreased in 85.5% of patients. B-cell analysis revealed 64.4% had reduced class-switched memory B cells, with 21.7% showing very low levels. Nine adult patients presented with late-onset combined immunodeficiency. Genetic testing, performed on 52 patients, identified underlying monogenic causes in 29 pediatric and 15 adult patients. LRBA deficiency was the most common genetic defect, found in seven pediatric and three adult patients. We developed a novel machine learning-based severity prediction model for CVID patients, utilizing readily available lymphocyte subsets, class-switched memory B cell counts, and serum immunoglobulin levels to provide an accessible and robust tool for predicting disease severity using Ameratunga’s clinical severity score. Random Forest outperformed other models across all metrics, achieving an accuracy of 0.853 (95% CI: 0.840–0.866). Feature importance analysis across all models identified Th-Tc ratio, CD19, and IgM levels as the most influential predictors for severity prediction. Our study highlights the diverse clinical and immunological features of CVID in Indian patients, emphasizing the need for early diagnosis and individualized management strategies. The machine learning model developed using commonly available immune parameters provide a robust tool for predicting disease severity, potentially guiding treatment strategies to improve patient outcomes.


  • Open Access

    Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I

    by Madhu Chhanda Mohanty, Mukesh Desai, Ahmad Mohammad, Amita Aggarwal, Geeta Govindaraj, Sagar Bhattad, Harsha Prasada Lashkari, Liza Rajasekhar, Harish Verma, Arun Kumar, et al.

    The emergence of vaccine-derived polioviruses (VDPVs) in patients with Primary Immunodeficiency (PID) is a threat to the polio-eradication program. In a first of its kind pilot study for successful screening and identification of VDPV excretion among patients with PID in India, enteroviruses were assessed in stool specimens of 154 PID patients across India in a period of two years. A total of 21.42% of patients were tested positive for enteroviruses, 2.59% tested positive for polioviruses (PV), whereas 18.83% of patients were positive for non-polio enteroviruses (NPEV). A male child of 3 years and 6 months of age diagnosed with Hyper IgM syndrome was detected positive for type1 VDPV (iVDPV1) with 1.6% nucleotide divergence from the parent Sabin strain. E21 (19.4%), E14 (9%), E11 (9%), E16 (7.5%), and CVA2 (7.5%) were the five most frequently observed NPEV types in PID patients. Patients with combined immunodeficiency were at a higher risk for enterovirus infection as compared to antibody deficiency. The high susceptibility of PID patients to enterovirus infection emphasizes the need for enhanced surveillance of these patients until the use of OPV is stopped. The expansion of PID surveillance and integration with a national program will facilitate early detection and follow-up of iVDPV excretion to mitigate the risk for iVDPV spread.


  • Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas‐mediated apoptotic pathway

    by Priyanka Setia, Umair Ahmed Bargir, Chandrakala Shanmukhaiah, Neha Jodhawat, Pallavi Gaikwad, Disha Vedpathak, Shubhankar Dutta, Rucha Kulkarni, Priyanka Kambli, Aparna Dalvi, et al.


  • Utility of HLA‐DR in screening panel for inborn errors of immunity

    by Reetika Malik Yadav, Neha Jodhawat, Maya Gupta, Aparna Dalvi, Umair Ahmad Bargir, Gouri Hule, Priyanka Setia, Shweta Shinde, Shilpi Saxena, Ankita Parab, et al.

    A comprehensive evaluation of immune parameters while screening for inborn errors of immunity (IEIs) provides valuable information about the underlying defect. In 2019, the ICMR‐National Institute of Immunohaematology adopted a screening panel modified from the Euroflow consortium‐recommended PIDOT tube, the difference being the addition of HLA‐DR. In the present study, we evaluate the utility of HLA‐DR in our screening panel. The HLA‐DR expression on CD3 + T, its CD4+ and CD8+ subsets, natural killer (NK) and double‐negative T cells (DNT) was compared between patients and controls. HLA‐DR expression on CD3+ T cells or its subsets was significantly elevated in SCID and Omenn's phenotype (P <.001), combined immunodeficiencies (P < .05) including DOCK8 and WAS, diseases of immune dysregulation including FHL (P < .0001) and ALPS (P < .05) and CVID with complications (P < .05). An absence of HLA‐DR marker can help in identifying cases of MHC II deficiency at the time of screening including atypical cases which present without reduction in CD4+ T cell counts and reversal of CD4+/CD8+ ratio. ROC analysis revealed a cut‐off of 14.62%, 19.11% and 1.5% for percentage HLA‐DR expression on CD3+ and CD8+ T cells and HLA‐DR on CD8/HLA‐DR on CD4, respectively, for FHL. Random forest analysis identified HLA‐DR (%) on NK cells, ratio of HLA‐DR CD8+/HLA‐DR CD4+, NK cell (%), T cell (%), HLA‐DR+ CD8(%) and CD45pos NK cell (%) as important predictors for FHL. Evaluation of HLA‐DR expression during screening can provide corroborative clues to the diagnosis of underlying IEI along with other immunological abnormalities.


  • CD8 + T Cells Exhibit an Exhausted Phenotype in Hemophagocytic Lymphohistiocytosis

    by Madhura G. Kelkar, Umair Ahmad Bargir, Reetika Malik-Yadav, Maya Gupta, Aparna Dalvi, Neha Jodhawat, Shweta Shinde, Manisha R. Madkaikar

    Purpose Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome mainly caused by uncontrolled activation of antigen presenting cells and CD8 T cells. CD8 T cell exhaustion is a known phenomenon in chronic viral infections and cancer. However, the role of T cell exhaustion is not yet identified in HLH in the background of persistent inflammation. So, currently, we have characterized the CD8 T cells using flow cytometry to understand the phenomenon of exhaustion in these cells in HLH. Methods We have comprehensively evaluated lymphocyte subsets and characterized CD8 T cells using immunophenotypic markers like PD1, TIM3, LAG3, Ki67, Granzyme B, etc. in a cohort of 21 HLH patients. Effector cytokine secretion and degranulation by CD8 T cells are also studied. Results Our findings indicate skewed lymphocyte subsets and aberrantly activated CD8 T cells in HLH. CD8 T cells exhibit significantly increased expression of PD1, TIM3, and LAG3 prominently in primary HLH as compared to controls. PD1 + CD8 T cells express elevated levels of Granzyme B and Ki67. Moreover, CD8 T cells are hypofunctional as evidenced by significantly reduced cytokine secretion and compromised CD107a degranulation. Conclusion The study has revealed that CD8 + cytotoxic T lymphocytes from HLH patients exhibited high expression of exhaustion markers with overall impaired function. To the best of our understanding, this is the first report suggesting functional exhaustion of CD8 T cells in both primary and secondary HLH. Future studies to understand the association of exhaustion with disease outcome are needed for its probable therapeutic implementation.